课题基金 / 基金详情

Control of Ocular Proliferation and Neuroprotection by Gene Therapy and Analysis of These Molecular Mechanisms.

Control of Ocular Proliferation and Neuroprotection by Gene Therapy and Analysis of These Molecular Mechanisms.
通过基因治疗控制眼部增殖和神经保护以及这些分子机制的分析。
批准号:
12671730
负责人:
OGATA Nahoko
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

OGATA Nahoko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We determine the changes in the expression of cytokines in cultured human retinal pigment epithelial (RPE) cells and rat retinas after laser photocoagulation. We found an up-regulation of pigment epithelium-derived factor (PEDF) and a down-regulation of angiogenic factors, i.e., vascular endothelial growth factor (VEGF) and suggested that PEDF play a role in inhibiting neovascularization by its anti-angiogenic activity.We also investigated the expression of PEDF and VEGF in a rat model of experimental choroidal neovascularization (CNV) and demonstrated that PEDF attributes the regression of CNV. We evaluated the transfection of LacZ gene and double stranded oligodeoxynucleotides(=decoy) by means of the hemagglutinating virus of Japan (HVJ) liposome method with intravitreal injection in a same model. The transfected decoy against NFk-B had effectively inhibited the development of CNV. Thus, our results suggest that the HVJ liposome method can be used as a gene therapy system for regulat … More ion of angionenic factors to treat the CNV in vivo.Ischemia-reperfusion injury model is a kind of retinal degeneration model which shows apoptosis in retina neuronal cells. Administration of PEDF had showed neuroprotective effects on retinal cells. Therefore, PEDF would be useful inpreventing neuronal degeneration in the inner retina resulting from ischemia.We reported the levels of PEDF and VEGF in the vitreous of patients with diabetic retinopathy, rhegmatogenous retinal detachment and priliferative vitreoretinopathy. PEDF in the vitreous was low in diabetic retinopathy and proliferative vitreoretinopathy, but high in rthgmatogenous retinal detachment. These results suggest that PEDF inhibits angiogenesis and cell proliferation, and that lower leverls of PEDF may result in active proliferative diabetic retinopathy and proliferative vitreoretinopathy. The results also suggest that higher levels of PEDF in the eyes with rhegmatogenous retinal detachment may act as a neuroprotective agent for the detached retina. Less
期刊论文(49)
专著(0)
科研奖励(0)
会议论文
Nahoko Ogata, Lin Wang al.: "Pigment Epithelium Derived Factor as a Neumpmtective Agent against Jschemic Refinal Injury"Current Eye Research. Vol.20. 245-252 (2001)
Nahoko Ogata、Lin Wang 等人:“色素上皮衍生因子作为抗缺血性再损伤的神经保护剂”当前眼部研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nahoko Ogata, Akira Ando, Masanobu Uyama et al.: "Expression of Cytokines and Transcription Factors in Photocoagulated Human Retinal Pigment Epithelial Cells"Gmefe's Archive for Clinical and Experimental Ophthalmology. Vol.239. 87-95 (2001)
Nahoko Ogata、Akira Ando、Masanobu Uyama 等人:“光凝人视网膜色素上皮细胞中细胞因子和转录因子的表达”Gmefe 临床和实验眼科档案。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
緒方奈保子(宇山昌延, 西村哲哉, 高橋寛二 編): "黄斑疾患 テキスト&アトラス"医学書院. (2000)
Naoko Ogata(由 Masanobu Uyama、Tetsuya Nishimura 和 Kanji Takahashi 编辑):《黄斑疾病文本与图集》Igaku Shoin (2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Rie Yamanaka, Nahoko Ogata, Chikako Yamamoto, Masanori Matsushita, Kouichi Matsuzaki, Masanobu Uyama et al.: "Expression of transforming growth factor-β receptors in normal rat retina and experimental choroidal neovascularization."Japanese Journal of Opht
Rie Yamanaka、Nahoko Ogata、Chikako Yamamoto、Masanori Matsushita、Kouichi Matsuzaki、Masanobu Uyama 等:“转化生长因子-β 受体在正常大鼠视网膜和实验性脉络膜新生血管中的表达。”Japan Journal of Opht
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
44
    Molecular biological study and treatment for diabetic retinopathy
    • 批准号:
      18591943
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.51万
    • 财政年份:
      2006
    • 负责人:
      OGATA Nahoko
    • 依托单位:
    Molecular biological analysis and treatment for diabetic retinopathy
    • 批准号:
      16591774
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      2004
    • 负责人:
      OGATA Nahoko
    • 依托单位:
    Molecular Mechanism and i Therapy for Choroidal Neovascularization
    • 批准号:
      14571694
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2002
    • 负责人:
      OGATA Nahoko
    • 依托单位:
    Gene Therapy and Transplantation of Retinal Pigment Epithelium for Ocular Proliferative Deseases and Retinal Degeneration
    • 批准号:
      10671662
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      1998
    • 负责人:
      OGATA Nahoko
    • 依托单位:
    国内基金
    海外基金
    PEDF介导糖尿病肾纤维化中近端肾小管上皮细胞脂质及能量可塑性的调控及机制研究
    • 批准号:
      JCZRLH202500704
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    PEDF对近端肾小管上皮细胞中脂肪酸代谢和能量的调控在糖尿病肾纤维化中的作用和机制研究
    • 批准号:
      JCZRLH202501039
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    神经保护PEDF17-mer基序结构域对干性AMD的保护作用及开发应用研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      赖坤贝
    • 依托单位:
    嗅黏膜间充质干细胞通过PEDF-PI3K/Akt/Nrf2通路减轻脑出血后高尔基体应激的机制研究
    • 批准号:
      2023JJ40819
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2023
    • 负责人:
      何佳霖
    • 依托单位: